Abstract:In transcatheter aortic valve replacement (TAVR) recipients, the optimal management of concomitant chronic obstructive coronary artery disease (CAD) remains unknown. Some advocate for pre-TAVR percutaneous coronary intervention, while others manage it expectantly. The aim of this study was to assess the impact of varying degrees and extent of untreated chronic obstructive CAD on TAVR and longer-term outcomes. The authors conducted a retrospective cohort study of TAVR recipients from January 2015 to November 2021, separating patients into stable non-obstructive or varying degrees of obstructive CAD. The major outcomes of interest were procedural all-cause mortality and complications, major adverse cardiovascular events, and post-TAVR unplanned coronary revascularization. Of the 1911 patients meeting inclusion, 75%, 6%, 10%, and 9% had non-obstructive, intermediate-risk, high-risk, and extreme-risk CAD, respectively. Procedural complication rates overall were low (death 0.4%, shock 0.1%, extracorporeal membrane oxygenation 0.1%), with no difference across groups. At a median follow-up of 21 months, rates of acute coronary syndrome and unplanned coronary revascularization were 0.7% and 0.5%, respectively, in the non-obstructive population, rising in incidence with increasing severity of CAD ( P < .001 for acute coronary syndrome/unplanned coronary revascularization). Multivariable analysis did not yield a significantly greater risk of all-cause mortality or major adverse cardiovascular events across groups. One-year acute coronary syndrome and unplanned coronary revascularization rates in time-to-event analyses were significantly greater in the non-obstructive (98%) vs. obstructive (94%) subsets ( P log-rank < .001). Transcatheter aortic valve replacement can be performed safely in patients with untreated chronic obstructive CAD, without portending higher procedural complication rates and with relatively low rates of unplanned coronary revascularization and acute coronary syndrome at 1 year. ( A ) Definitions for the four categories of coronary artery disease (CAD) studied alongside the breakdown of transcatheter aortic valve replacement (TAVR) valve type with 91% balloon-expandable valves (BEV) and 9% self-expanding valves (SEV). Procedural complication rates were minimal across the 1911 patients studied. ( B ) Cumulative incidence curve of major adverse cardiovascular events (MACE) [acute coronary syndrome (ACS), stroke, or heart failure hospitalizations] demonstrating no significant difference between obstructive and non-obstructive groups ( P = .609) ( C ) Cumulative incidence curve of unplanned coronary revascularization showing a significant difference between obstructive and non-obstructive groups ( P = .006). ( D ) Multivariable analyses for all-cause mortality and MACE. CI, confidence interval; ECMO, extracorporeal membrane oxygenation; HR, hazard ratio; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; N/A, not available; RCA, right coronary artery.

Procedural and long‐term outcome among patients undergoing expedited trans‐catheter aortic valve replacement

Clinical practice and prognosis of emergent transcatheter aortic valve replacement

Outcomes of Emergency Transcatheter Aortic Valve Replacement

Over a Decade of Practice

Mortality rates in patients undergoing urgent versus elective transcatheter aortic valve replacement: a systematic review and meta-analysis

Long term outcomes of patients with decompensated aortic stenosis undergoing urgent transcatheter aortic valve implantation: a TAVI-NOR subs-study

30-Day Outcomes after Surgical or Transapical Aortic Valve Replacement in Symptomatic Aortic Regurgitation

Urgent transcatheter aortic valve implantation in an all-comer population: a single-centre experience

A Comparative Study of TAVR versus SAVR in Moderate and High-Risk Surgical Patients: Hospital Outcome and Midterm Results

Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach

Anaesthetic and Procedural-Related Complications in Transcatheter Aortic Valve Implantation (TAVI) and Its Outcome: A Retrospective Observational Study

Short- and intermediate-term outcomes of transcatheter aortic valve replacement in low-risk patients: A meta-analysis and systematic review

Early and Mid-Term Outcomes of Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement: Updated Systematic Review and Meta-Analysis

Management and Outcome of Acute Ischemic Stroke Complicating Transcatheter Aortic Valve Replacement

Immediate results of transcatheter aortic valve implantation

Outcomes after transaortic transcatheter aortic valve implantation: long-term findings from the European ROUTE†

Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement

Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement

Safety outcomes of new versus old generation transcatheter aortic valves

Transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and cardiogenic shock

Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations